Selected research
Industry Research
Medical Devices Genotoxicity Testing Service Industry Research Report 2026
Market perspective
The global Medical Devices Genotoxicity Testing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Medical Devices Genotoxicity Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Medical Devices Genotoxicity Testing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Medical Devices Genotoxicity Testing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Medical Devices Genotoxicity Testing Service include TÜV SÜD, NAMSA, Eurofins Scientific, SGS SA, Nelson Labs, CD Bioarticle, UL Solutions, Measurlabs and STC Group, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Medical Devices Genotoxicity Testing Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Medical Devices Genotoxicity Testing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Devices Genotoxicity Testing Service Market by Company
TÜV SÜD
NAMSA
Eurofins Scientific
SGS SA
Nelson Labs
CD Bioarticle
UL Solutions
Measurlabs
STC Group
STEMart
Porsolt
TheraIndx
GBA Group
Adita Biosys
Adgyl Lifesciences
Medical Devices Genotoxicity Testing Service Segment by Type
In Vitro Testing
In Vivo Testing
Medical Devices Genotoxicity Testing Service Segment by Application
Implantable Devices
Polymer Devices
Drug Coating/Combination Devices
Others
Medical Devices Genotoxicity Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Devices Genotoxicity Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Devices Genotoxicity Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Devices Genotoxicity Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Medical Devices Genotoxicity Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- In Vitro Testing
- In Vivo Testing
Applications
- Implantable Devices
- Polymer Devices
- Drug Coating/Combination Devices
- Others
Companies covered
- TÜV SÜD
- NAMSA
- Eurofins Scientific
- SGS SA
- Nelson Labs
- CD Bioarticle
- UL Solutions
- Measurlabs
- STC Group
- STEMart
- Porsolt
- TheraIndx
- GBA Group
- Adita Biosys
- Adgyl Lifesciences
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Medical Devices Genotoxicity Testing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 In Vitro Testing
- 2.2.3 In Vivo Testing
- 2.3 Medical Devices Genotoxicity Testing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Implantable Devices
- 2.3.3 Polymer Devices
- 2.3.4 Drug Coating/Combination Devices
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Medical Devices Genotoxicity Testing Service Breakdown Data by Type
- 3.1 Global Medical Devices Genotoxicity Testing Service Historic Market Size by Type (2021-2026)
- 3.2 Global Medical Devices Genotoxicity Testing Service Forecasted Market Size by Type (2027-2032)
4 Medical Devices Genotoxicity Testing Service Breakdown Data by Application
- 4.1 Global Medical Devices Genotoxicity Testing Service Historic Market Size by Application (2021-2026)
- 4.2 Global Medical Devices Genotoxicity Testing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Medical Devices Genotoxicity Testing Service Market Perspective (2021-2032)
- 5.2 Global Medical Devices Genotoxicity Testing Service Growth Trends by Region
- 5.2.1 Global Medical Devices Genotoxicity Testing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Medical Devices Genotoxicity Testing Service Historic Market Size by Region (2021-2026)
- 5.2.3 Medical Devices Genotoxicity Testing Service Forecasted Market Size by Region (2027-2032)
- 5.3 Medical Devices Genotoxicity Testing Service Market Dynamics
- 5.3.1 Medical Devices Genotoxicity Testing Service Industry Trends
- 5.3.2 Medical Devices Genotoxicity Testing Service Market Drivers
- 5.3.3 Medical Devices Genotoxicity Testing Service Market Challenges
- 5.3.4 Medical Devices Genotoxicity Testing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Medical Devices Genotoxicity Testing Service Players by Revenue
- 6.1.1 Global Top Medical Devices Genotoxicity Testing Service Players by Revenue (2021-2026)
- 6.1.2 Global Medical Devices Genotoxicity Testing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Medical Devices Genotoxicity Testing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Medical Devices Genotoxicity Testing Service Head Office and Area Served
- 6.4 Global Medical Devices Genotoxicity Testing Service Players, Product Type & Application
- 6.5 Global Medical Devices Genotoxicity Testing Service Manufacturers Established Date
- 6.6 Global Medical Devices Genotoxicity Testing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Medical Devices Genotoxicity Testing Service Market Size (2021-2032)
- 7.2 North America Medical Devices Genotoxicity Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Medical Devices Genotoxicity Testing Service Market Size by Country (2021-2026)
- 7.4 North America Medical Devices Genotoxicity Testing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Medical Devices Genotoxicity Testing Service Market Size (2021-2032)
- 8.2 Europe Medical Devices Genotoxicity Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Medical Devices Genotoxicity Testing Service Market Size by Country (2021-2026)
- 8.4 Europe Medical Devices Genotoxicity Testing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Medical Devices Genotoxicity Testing Service Market Size (2021-2032)
- 9.2 Asia-Pacific Medical Devices Genotoxicity Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Medical Devices Genotoxicity Testing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Medical Devices Genotoxicity Testing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Medical Devices Genotoxicity Testing Service Market Size (2021-2032)
- 10.2 South America Medical Devices Genotoxicity Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Medical Devices Genotoxicity Testing Service Market Size by Country (2021-2026)
- 10.4 South America Medical Devices Genotoxicity Testing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size (2021-2032)
- 11.2 Middle East & Africa Medical Devices Genotoxicity Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 TÜV SÜD
- 12.1.1 TÜV SÜD Company Information
- 12.1.2 TÜV SÜD Business Overview
- 12.1.3 TÜV SÜD Revenue in Medical Devices Genotoxicity Testing Service Business (2021-2026)
- 12.1.4 TÜV SÜD Medical Devices Genotoxicity Testing Service Product Portfolio
- 12.1.5 TÜV SÜD Recent Developments
- 12.2 NAMSA
- 12.2.1 NAMSA Company Information
- 12.2.2 NAMSA Business Overview
- 12.2.3 NAMSA Revenue in Medical Devices Genotoxicity Testing Service Business (2021-2026)
- 12.2.4 NAMSA Medical Devices Genotoxicity Testing Service Product Portfolio
- 12.2.5 NAMSA Recent Developments
- 12.3 Eurofins Scientific
- 12.3.1 Eurofins Scientific Company Information
- 12.3.2 Eurofins Scientific Business Overview
- 12.3.3 Eurofins Scientific Revenue in Medical Devices Genotoxicity Testing Service Business (2021-2026)
- 12.3.4 Eurofins Scientific Medical Devices Genotoxicity Testing Service Product Portfolio
- 12.3.5 Eurofins Scientific Recent Developments
- 12.4 SGS SA
- 12.4.1 SGS SA Company Information
- 12.4.2 SGS SA Business Overview
- 12.4.3 SGS SA Revenue in Medical Devices Genotoxicity Testing Service Business (2021-2026)
- 12.4.4 SGS SA Medical Devices Genotoxicity Testing Service Product Portfolio
- 12.4.5 SGS SA Recent Developments
- 12.5 Nelson Labs
- 12.5.1 Nelson Labs Company Information
- 12.5.2 Nelson Labs Business Overview
- 12.5.3 Nelson Labs Revenue in Medical Devices Genotoxicity Testing Service Business (2021-2026)
- 12.5.4 Nelson Labs Medical Devices Genotoxicity Testing Service Product Portfolio
- 12.5.5 Nelson Labs Recent Developments
- 12.6 CD Bioarticle
- 12.6.1 CD Bioarticle Company Information
- 12.6.2 CD Bioarticle Business Overview
- 12.6.3 CD Bioarticle Revenue in Medical Devices Genotoxicity Testing Service Business (2021-2026)
- 12.6.4 CD Bioarticle Medical Devices Genotoxicity Testing Service Product Portfolio
- 12.6.5 CD Bioarticle Recent Developments
- 12.7 UL Solutions
- 12.7.1 UL Solutions Company Information
- 12.7.2 UL Solutions Business Overview
- 12.7.3 UL Solutions Revenue in Medical Devices Genotoxicity Testing Service Business (2021-2026)
- 12.7.4 UL Solutions Medical Devices Genotoxicity Testing Service Product Portfolio
- 12.7.5 UL Solutions Recent Developments
- 12.8 Measurlabs
- 12.8.1 Measurlabs Company Information
- 12.8.2 Measurlabs Business Overview
- 12.8.3 Measurlabs Revenue in Medical Devices Genotoxicity Testing Service Business (2021-2026)
- 12.8.4 Measurlabs Medical Devices Genotoxicity Testing Service Product Portfolio
- 12.8.5 Measurlabs Recent Developments
- 12.9 STC Group
- 12.9.1 STC Group Company Information
- 12.9.2 STC Group Business Overview
- 12.9.3 STC Group Revenue in Medical Devices Genotoxicity Testing Service Business (2021-2026)
- 12.9.4 STC Group Medical Devices Genotoxicity Testing Service Product Portfolio
- 12.9.5 STC Group Recent Developments
- 12.10 STEMart
- 12.10.1 STEMart Company Information
- 12.10.2 STEMart Business Overview
- 12.10.3 STEMart Revenue in Medical Devices Genotoxicity Testing Service Business (2021-2026)
- 12.10.4 STEMart Medical Devices Genotoxicity Testing Service Product Portfolio
- 12.10.5 STEMart Recent Developments
- 12.11 Porsolt
- 12.11.1 Porsolt Company Information
- 12.11.2 Porsolt Business Overview
- 12.11.3 Porsolt Revenue in Medical Devices Genotoxicity Testing Service Business (2021-2026)
- 12.11.4 Porsolt Medical Devices Genotoxicity Testing Service Product Portfolio
- 12.11.5 Porsolt Recent Developments
- 12.12 TheraIndx
- 12.12.1 TheraIndx Company Information
- 12.12.2 TheraIndx Business Overview
- 12.12.3 TheraIndx Revenue in Medical Devices Genotoxicity Testing Service Business (2021-2026)
- 12.12.4 TheraIndx Medical Devices Genotoxicity Testing Service Product Portfolio
- 12.12.5 TheraIndx Recent Developments
- 12.13 GBA Group
- 12.13.1 GBA Group Company Information
- 12.13.2 GBA Group Business Overview
- 12.13.3 GBA Group Revenue in Medical Devices Genotoxicity Testing Service Business (2021-2026)
- 12.13.4 GBA Group Medical Devices Genotoxicity Testing Service Product Portfolio
- 12.13.5 GBA Group Recent Developments
- 12.14 Adita Biosys
- 12.14.1 Adita Biosys Company Information
- 12.14.2 Adita Biosys Business Overview
- 12.14.3 Adita Biosys Revenue in Medical Devices Genotoxicity Testing Service Business (2021-2026)
- 12.14.4 Adita Biosys Medical Devices Genotoxicity Testing Service Product Portfolio
- 12.14.5 Adita Biosys Recent Developments
- 12.15 Adgyl Lifesciences
- 12.15.1 Adgyl Lifesciences Company Information
- 12.15.2 Adgyl Lifesciences Business Overview
- 12.15.3 Adgyl Lifesciences Revenue in Medical Devices Genotoxicity Testing Service Business (2021-2026)
- 12.15.4 Adgyl Lifesciences Medical Devices Genotoxicity Testing Service Product Portfolio
- 12.15.5 Adgyl Lifesciences Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst